Treatment Sequencing and Independent Outcomes of First- and Second-Line Chemotherapy in a Retrospective Series of Patients with Biliary Tract Cancer
Giorgio Frega, Andrea Palloni, Chiara Deiana, Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi, Manuel Diez-Alonso · 2024
Read Treatment Sequencing and Independent Outcomes of First- and Second-Line Chemotherapy in a Retrospective Series of Patients with Biliary Tract Cancer by Giorgio Frega, Andrea Palloni, Chiara Deiana, Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi, Manuel Diez-Alonso (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642358.txt.
Description
Giorgio Frega and co-authors published this study in 2024. It reviews treatment sequences for biliary tract cancer, a rare and aggressive cancer of the bile ducts and gallbladder, at one Italian referral hospital. The series covers the years before immunotherapy arrived, when chemotherapy order was the main strategic choice.
Fifty-six patients who received at least three rounds of therapy were analyzed. The standard sequence, a gemcitabine-cisplatin doublet first and a fluorouracil regimen second, was compared with every other combination doctors had chosen. Survival did not differ significantly between the standard path and the alternatives, in either line. The authors note their filter, patients fit enough for three lines, selects long survivors by construction. Even so, the series is among the first to test sequencing itself in this cancer. It suggests flexibility in regimen choice costs little, leaving room to tailor by tolerance and patient preference.
Catalog record
| CREATOR | Giorgio Frega, Andrea Palloni, Chiara Deiana, Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi, Manuel Diez-Alonso |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |